Literature DB >> 11591762

Endothelial cell costimulation of T cell activation through CD58-CD2 interactions involves lipid raft aggregation.

J Mestas1, C C Hughes.   

Abstract

Human endothelial cells (EC) costimulate CD4(+) memory T cell activation through CD58-CD2 interactions. In this study we tested the hypothesis that EC activate distinct costimulatory pathways in T cells that target specific transcription factors. AP-1, composed of fos and jun proteins, is a critical effector of TCR signaling and binds several sites in the IL-2 promoter. EC augment c-fos promoter activity in T cells; however, deletion analysis reveals no transcription factor binding sites in the promoter uniquely responsive to EC costimulation. Overexpression of AP-1 proteins in T cells augments the activity of an AP-1-luciferase reporter gene equally in the absence or the presence of EC costimulation. Interestingly, EC stimulate a similar 2- to 3-fold up-regulation of AP-1, NF-AT, NF-kappaB, and NF-IL-2-luciferase reporters. CD2 mAbs completely block EC effects on all of these pathways, as well as costimulation of IL-2 secretion. We conclude that EC costimulation through CD2 does not trigger a single distinct costimulatory pathway in T cells, but rather, it amplifies several pathways downstream of the TCR. Indeed, we find that early EC costimulation acts "upstream" of the TCR by promoting lipid raft aggregation, thus amplifying TCR signaling. Soluble CD2 mAbs block EC-induced raft aggregation, whereas cross-linking CD2 promotes aggregation. These data are consistent with the critical role of CD2 in organizing the T cell-APC contact zone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591762     DOI: 10.4049/jimmunol.167.8.4378

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Chronic beryllium disease: an updated model interaction between innate and acquired immunity.

Authors:  Richard T Sawyer; Lisa A Maier
Journal:  Biometals       Date:  2010-10-28       Impact factor: 2.949

2.  Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells.

Authors:  Gregory M Nelson; Timothy P Padera; Igor Garkavtsev; Toshi Shioda; Rakesh K Jain
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

3.  Lung dendritic cells at the innate-adaptive immune interface.

Authors:  Tracy Voss Condon; Richard T Sawyer; Matthew J Fenton; David W H Riches
Journal:  J Leukoc Biol       Date:  2011-08-01       Impact factor: 4.962

Review 4.  Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice.

Authors:  Michael A Brehm; Alvin C Powers; Leonard D Shultz; Dale L Greiner
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

5.  Endothelial cells promote human immunodeficiency virus replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT.

Authors:  Jaehyuk Choi; Jason Walker; Kristina Talbert-Slagle; Paulette Wright; Jordan S Pober; Louis Alexander
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Multifactorial relationships between intramammary invasion by Staphylococcus aureus and bovine leukocyte markers.

Authors:  Ariel L Rivas; Steven J Schwager; Rubén N González; Fred W Quimby; Kevin L Anderson
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

7.  A simple promoter containing two Sp1 sites controls the expression of sterol-regulatory-element-binding protein 1a (SREBP-1a).

Authors:  Chengkang Zhang; Dong-Ju Shin; Timothy F Osborne
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

Review 8.  Functions of lipid raft membrane microdomains at the blood-brain barrier.

Authors:  Aurore Dodelet-Devillers; Romain Cayrol; Jack van Horssen; Arsalan S Haqqani; Helga E de Vries; Britta Engelhardt; John Greenwood; Alexandre Prat
Journal:  J Mol Med (Berl)       Date:  2009-05-30       Impact factor: 4.599

9.  Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes.

Authors:  Haloom Rafehi; Antony Kaspi; Mark Ziemann; Jun Okabe; Tom C Karagiannis; Assam El-Osta
Journal:  Epigenetics       Date:  2017       Impact factor: 4.528

10.  T cells as pioneers: antigen-specific T cells condition inflamed sites for high-rate antigen-non-specific effector cell recruitment.

Authors:  Saeed Ghani; Markus Feuerer; Cornelia Doebis; Uta Lauer; Christoph Loddenkemper; Jochen Huehn; Alf Hamann; Uta Syrbe
Journal:  Immunology       Date:  2009-03-26       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.